CEACAM1 and fatty liver disease: Since hyperinsulinemia and reduced hepatic CEACAM1 can induce hepatic steatosis, thereby potentially amplifying the effect of oleate [25,26,27], we assessed hepatic fat content using oil-red-O staining.